Active Ingredient(s): Teniposide
FDA Approved: * July 14, 1992
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Vumon Overview

Teniposide (trade name Vumon) is a chemotherapeutic medication[1] used in the treatment of childhood acute lymphocytic leukemia (ALL), Hodgkin's lymphoma, certain brain tumours, and other types of cancer.[2] It is in a class of drugs known as podophyllotoxin derivatives and slows the growth of cancer cells in the body.[3] Contents 1 Medical uses 1.1 Administration 2 Contraindications 3 Side effects 4 History 5 Pharmacology 5.1 Mechanism of...

Read more Vumon Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Vumon Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 10mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Vumon: (1 result)

Sorted by National Drug Code
  • 0015-3075 Vumon 10 mg/ml Intravenous Injection, Solution by E.r. Squibb & Sons, L.L.C.

Other drugs which contain Teniposide or a similar ingredient: (1 result)